Prostate News and Research

RSS

Lifetime heavy drinking sharply raises colorectal cancer risk, major US study finds

Lifetime alcohol intake, not just recent drinking, is associated with colorectal cancer risk in older adults followed in the PLCO Cancer Screening Trial. Heavy and consistent long-term drinking was linked to higher colorectal cancer risk, while alcohol cessation was associated with lower odds of early, nonadvanced adenomas.

28 Jan 2026

Novel laser focal therapy device shows promising results for prostate cancer treatment

Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in minimally invasive, focal treatment options has been growing for certain patients.

28 Jan 2026

New trial tests strategies to protect heart health during prostate cancer therapy

City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation's top cancer centers by U.S. News & World Report, has opened a phase 2 clinical trial comparing three different strategies for protecting heart health in prostate cancer patients who receive androgen deprivation therapy (ADT), a potentially lifesaving hormone therapy.

26 Jan 2026

Lifetime alcohol consumption associated with higher risk of colorectal cancer

Studies have demonstrated a link between alcohol consumption and an elevated risk of colorectal cancer. New research now reveals that higher lifetime alcohol consumption is also associated with a higher risk,

26 Jan 2026

Orphan noncoding RNAs define cancer identity and enable blood-based monitoring

We knew we had something interesting with T3p, a single small RNA found in breast cancer but absent from normal tissue.

24 Jan 2026

Metabolic reprogramming drives prostate cancer progression and treatment resistance

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy (ADT), the disease often progresses to castration-resistant prostate cancer (CRPC).

24 Jan 2026

Pre-surgical medication use grows for pancreatic, gynecologic, and abdominal lining cancers

The second annual report from the National Cancer Database (NCDB) of the American College of Surgeons (ACS) documents a substantial rise in medication treatments, such as chemotherapy, immunotherapy, and hormone therapy, used before surgery to treat many cancers, often allowing less invasive surgery and helping clinicians assess how a patient's cancer responds to medication to guide the most effective treatment options.

22 Jan 2026

Lung cancer deaths leveling off for EU women, except in Spain

After increasing for more than 25 years, lung cancer death rates are finally levelling off among women in European Union (EU) countries apart from Spain, according to predictions of mortality rates from the disease for 2026.

19 Jan 2026

PSA-based tool improves decision making for prostate cancer screening and treatment

Prostate cancer is the second-leading cause of cancer death in American men.

16 Jan 2026

Study tests combined targeted radiopharmaceuticals and precision radiation for recurrent prostate cancer

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether combining precision radiation with a targeted radioactive therapy drug can help patients with recurrent prostate cancer delay progression, while delaying or avoiding the side effects of long-term hormone therapy.

16 Jan 2026

Cancer mortality drops 34% as treatments and early detection improve

The 2026 cancer statistics reveal improved survival rates but highlight persistent inequities in cancer incidence and mortality across different populations.

16 Jan 2026

Common food preservatives may raise cancer risk

Higher intake of certain food preservatives is associated with increased cancer rates, particularly breast and prostate cancers, highlighting safety concerns.

13 Jan 2026

Whole-genome sequencing improves PARP inhibitor treatment prediction

A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely to benefit from PARP inhibitor cancer treatments, according to a study led by Weill Cornell Medicine and NewYork-Presbyterian investigators.

12 Jan 2026

AI trained on sleep data predicts future disease and mortality years in advance

The SleepFM model reveals how sleep analysis can predict disease risk, offering insights into sleep's role as a vital health indicator for early intervention.

8 Jan 2026

Advanced AI provides accurate guidance for prostate cancer patients

Mayo Clinic researchers have developed and evaluated MedEduChat, an electronic health record (EHR) that works with a large language model to provide accurate, patient-specific prostate cancer education.

7 Jan 2026

Day case surgery linked to significant readmission and chronic pain risks

Two new studies published in Anaesthesia (the journal of the Association of Anaesthetists) analyzing pain and other factors connected with day surgery in the UK show that around 1 in 8 patients having day-case surgery end up not going home and instead are admitted to hospital for various complications.

7 Jan 2026

Dietary exposure to food preservatives associated with higher cancer incidence

Higher intake of food preservatives, widely used in industrially processed foods and beverages to extend shelf-life, is associated with a modestly increased risk of cancer, finds a study from France published by The BMJ today.

7 Jan 2026

Cornell-developed nanoparticles improve cancer immunotherapy effectiveness

A class of ultrasmall fluorescent core-shell silica nanoparticles developed at Cornell is showing an unexpected ability to rally the immune system against melanoma and dramatically improve the effectiveness of cancer immunotherapy, according to a new study led by Weill Cornell Medicine and Cornell Engineering researchers.

7 Jan 2026

Breakthrough treatment for advanced prostate cancer could eliminate severe side effects

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving therapy.

7 Jan 2026

AI model can predict a person's disease risk using sleep data

A poor night's sleep portends a bleary-eyed next day, but it could also hint at diseases that will strike years down the road.

6 Jan 2026

Prostate News and Research

Lifetime heavy drinking sharply raises colorectal cancer risk, major US study finds

Novel laser focal therapy device shows promising results for prostate cancer treatment

New trial tests strategies to protect heart health during prostate cancer therapy

Lifetime alcohol consumption associated with higher risk of colorectal cancer

Orphan noncoding RNAs define cancer identity and enable blood-based monitoring

Metabolic reprogramming drives prostate cancer progression and treatment resistance

Pre-surgical medication use grows for pancreatic, gynecologic, and abdominal lining cancers

Lung cancer deaths leveling off for EU women, except in Spain

PSA-based tool improves decision making for prostate cancer screening and treatment

Study tests combined targeted radiopharmaceuticals and precision radiation for recurrent prostate cancer

Cancer mortality drops 34% as treatments and early detection improve

Common food preservatives may raise cancer risk

Whole-genome sequencing improves PARP inhibitor treatment prediction

AI trained on sleep data predicts future disease and mortality years in advance

Advanced AI provides accurate guidance for prostate cancer patients

Day case surgery linked to significant readmission and chronic pain risks

Dietary exposure to food preservatives associated with higher cancer incidence

Cornell-developed nanoparticles improve cancer immunotherapy effectiveness

Breakthrough treatment for advanced prostate cancer could eliminate severe side effects

AI model can predict a person's disease risk using sleep data

What to know about prostate cancer eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News